LEVBIO — Level Bio AB (publ) Income Statement
0.000.00%
Last trade - 00:00- SEK29.96m
- SEK28.88m
- SEK25.10m
- 26
- 13
- 59
- 20
Annual income statement for Level Bio AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | PRESS | ARS | PRESS |
| Standards: | SAS | SAS | — | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 23.7 | 44.7 | 34.7 | 26.1 | 25.1 |
| Cost of Revenue | |||||
| Gross Profit | 9.32 | 18.6 | — | 12.3 | 13.5 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 22.2 | 39.4 | 37 | 35.8 | 33.2 |
| Operating Profit | 1.55 | 5.26 | -2.33 | -9.73 | -8.08 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 1.52 | 5.21 | -2.41 | -9.69 | -8.19 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.51 | 5.16 | -2.22 | -9.48 | -7.87 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 1.51 | 5.16 | -2.22 | -9.48 | -7.87 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.51 | 5.16 | -2.22 | -9.48 | -7.87 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.029 | 0.089 | -0.035 | -0.149 | -0.115 |
| Dividends per Share |